Silexion Therapeutics Corp. (SLXN) Institutional Ownership

What the institutions did with SLXN last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.

Managers reporting

9

filed a 13F this quarter

Managers holding

6

-1 on the quarter

Buyers

3

2 opened new

Sellers

6

3 sold out entirely

Buyer share

33.3%

of managers who traded it

Breadth

-33.3

net buyers, as a share of those trading

Only 9 managers reported a position this quarter, so the percentages above describe a very small sample.

Largest holders

Manager	Shares	% of reported
HRT FINANCIAL LP	15.2K	89.3%
UBS Group AG	1.4K	8.3%
MONTAG A & ASSOCIATES INC	300	1.8%
ROYAL BANK OF CANADA	76	0.4%
Pflug Koory, LLC	33	0.2%
SBI Securities Co., Ltd.	2	0.0%

Largest changes

Manager	Action	Previous	Current	Change
CITADEL ADVISORS LLC	Sold Out	20.9K	0	-20.9K
HRT FINANCIAL LP	New	0	15.2K	+15.2K
TWO SIGMA SECURITIES, LLC	Sold Out	11.7K	0	-11.7K
MONTAG A & ASSOCIATES INC	Reduced	3.0K	300	-2.7K
UBS Group AG	Increased	517	1.4K	+894
Pflug Koory, LLC	Reduced	333	33	-300
ROYAL BANK OF CANADA	New	0	76	+76
JONES FINANCIAL COMPANIES LLLP	Sold Out	26	0	-26
SBI Securities Co., Ltd.	Reduced	20	2	-18

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.